<VariationArchive RecordType="classified" VariationID="2584485" VariationName="NM_005251.3(FOXC2):c.908_923dup (p.Pro309fs)" VariationType="Duplication" Accession="VCV002584485" Version="1" NumberOfSubmissions="1" NumberOfSubmitters="1" DateLastUpdated="2023-10-28" DateCreated="2023-10-21" MostRecentSubmission="2023-10-21">
  <RecordStatus>current</RecordStatus>
  <Species>Homo sapiens</Species>
  <ClassifiedRecord>
    <SimpleAllele AlleleID="2752048" VariationID="2584485">
      <GeneList>
        <Gene Symbol="FOXC2" FullName="forkhead box C2" GeneID="2303" HGNC_ID="HGNC:3801" Source="submitted" RelationshipType="within single gene">
          <Location>
            <CytogeneticLocation>16q24.1</CytogeneticLocation>
            <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86566829" stop="86569728" display_start="86566829" display_stop="86569728" Strand="+" />
            <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86600856" stop="86602538" display_start="86600856" display_stop="86602538" Strand="+" />
          </Location>
          <OMIM>602402</OMIM>
          <Haploinsufficiency last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">Sufficient evidence for dosage pathogenicity</Haploinsufficiency>
          <Triplosensitivity last_evaluated="2013-11-26" ClinGen="https://www.ncbi.nlm.nih.gov/projects/dbvar/ISCA/isca_gene.cgi?sym=FOXC2">No evidence available</Triplosensitivity>
        </Gene>
      </GeneList>
      <Name>NM_005251.3(FOXC2):c.908_923dup (p.Pro309fs)</Name>
      <CanonicalSPDI>NC_000016.10:86568239:CGCTGCCCTACGCCGCCGC:CGCTGCCCTACGCCGCCGCTGCCCTACGCCGCCGC</CanonicalSPDI>
      <VariantType>Duplication</VariantType>
      <Location>
        <CytogeneticLocation>16q24.1</CytogeneticLocation>
        <SequenceLocation Assembly="GRCh38" AssemblyAccessionVersion="GCF_000001405.38" forDisplay="true" AssemblyStatus="current" Chr="16" Accession="NC_000016.10" start="86568239" stop="86568240" display_start="86568239" display_stop="86568240" variantLength="16" positionVCF="86568239" referenceAlleleVCF="G" alternateAlleleVCF="GCGCTGCCCTACGCCGC" />
        <SequenceLocation Assembly="GRCh37" AssemblyAccessionVersion="GCF_000001405.25" AssemblyStatus="previous" Chr="16" Accession="NC_000016.9" start="86601845" stop="86601846" display_start="86601845" display_stop="86601846" variantLength="16" positionVCF="86601845" referenceAlleleVCF="G" alternateAlleleVCF="GCGCTGCCCTACGCCGC" />
      </Location>
      <ProteinChange>P309fs</ProteinChange>
      <HGVSlist>
        <HGVS Assembly="GRCh38" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.10" sequenceAccession="NC_000016" sequenceVersion="10" change="g.86568243_86568258dup" Assembly="GRCh38">
            <Expression>NC_000016.10:g.86568243_86568258dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Assembly="GRCh37" Type="genomic, top-level">
          <NucleotideExpression sequenceAccessionVersion="NC_000016.9" sequenceAccession="NC_000016" sequenceVersion="9" change="g.86601849_86601864dup" Assembly="GRCh37">
            <Expression>NC_000016.9:g.86601849_86601864dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="NG_012025.2" sequenceAccession="NG_012025" sequenceVersion="2" change="g.6415_6430dup">
            <Expression>NG_012025.2:g.6415_6430dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="NM_005251.3" sequenceAccession="NM_005251" sequenceVersion="3" change="c.908_923dup" MANESelect="true">
            <Expression>NM_005251.3:c.908_923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="NP_005242.1" sequenceAccession="NP_005242" sequenceVersion="1" change="p.Pro309fs">
            <Expression>NP_005242.1:p.Pro309fs</Expression>
          </ProteinExpression>
          <MolecularConsequence ID="SO:0001589" Type="frameshift variant" DB="SO" />
        </HGVS>
        <HGVS Type="genomic">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292" sequenceAccession="LRG_1292">
            <Expression>LRG_1292:g.6415_6430dup</Expression>
          </NucleotideExpression>
        </HGVS>
        <HGVS Type="coding">
          <NucleotideExpression sequenceAccessionVersion="LRG_1292t1" sequenceAccession="LRG_1292t1">
            <Expression>LRG_1292t1:c.908_923dup</Expression>
          </NucleotideExpression>
          <ProteinExpression sequenceAccessionVersion="LRG_1292p1" sequenceAccession="LRG_1292p1" change="p.Pro309fs">
            <Expression>LRG_1292p1:p.Pro309fs</Expression>
          </ProteinExpression>
        </HGVS>
      </HGVSlist>
    </SimpleAllele>
    <RCVList>
      <RCVAccession Title="NM_005251.3(FOXC2):c.908_923dup (p.Pro309fs) AND Distichiasis-lymphedema syndrome" Accession="RCV003335925" Version="1">
        <ClassifiedConditionList TraitSetID="1971">
          <ClassifiedCondition DB="MedGen" ID="C0265345">Distichiasis-lymphedema syndrome</ClassifiedCondition>
        </ClassifiedConditionList>
        <RCVClassifications>
          <GermlineClassification>
            <ReviewStatus>criteria provided, single submitter</ReviewStatus>
            <Description SubmissionCount="1">Pathogenic</Description>
          </GermlineClassification>
        </RCVClassifications>
      </RCVAccession>
    </RCVList>
    <Classifications>
      <GermlineClassification NumberOfSubmissions="1" NumberOfSubmitters="1" DateCreated="2023-10-21" MostRecentSubmission="2023-10-21">
        <ReviewStatus>criteria provided, single submitter</ReviewStatus>
        <Description>Pathogenic</Description>
        <ConditionList>
          <TraitSet ID="1971" Type="Disease" ContributesToAggregateClassification="true">
            <Trait ID="2577" Type="Disease">
              <Name>
                <ElementValue Type="Alternate">Lymphedema with distichiasis</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Alternate">Hereditary lymphedema-distichiasis syndrome (subtype)</ElementValue>
              </Name>
              <Name>
                <ElementValue Type="Preferred">Distichiasis-lymphedema syndrome</ElementValue>
                <XRef ID="Lymphedema+distichiasis+syndrome/4357" DB="Genetic Alliance" />
                <XRef ID="8634009" DB="SNOMED CT" />
              </Name>
              <AttributeSet>
                <Attribute Type="public definition">Lymphedema-distichiasis syndrome (referred to as LDS in this GeneReview) is characterized by lower-limb lymphedema, and distichiasis (aberrant eyelashes ranging from a full set of extra eyelashes to a single hair). Lymphedema typically appears in late childhood or puberty, is confined to the lower limbs with or without involvement of the external genitalia, and is often asymmetric; severity varies within families. Males develop edema at an earlier age and have more problems with cellulitis than females. Distichiasis, which may be present at birth, is observed in 94% of affected individuals. About 75% of affected individuals have ocular findings including corneal irritation, recurrent conjunctivitis, and photophobia; other common findings include varicose veins and ptosis.</Attribute>
                <XRef ID="NBK1457" DB="GeneReviews" />
              </AttributeSet>
              <AttributeSet>
                <Attribute Type="GARD id" integerValue="333" />
                <XRef ID="333" DB="Office of Rare Diseases" />
              </AttributeSet>
              <Citation Type="review" Abbrev="GeneReviews">
                <ID Source="PubMed">20301630</ID>
                <ID Source="BookShelf">NBK1457</ID>
              </Citation>
              <XRef ID="33001" DB="Orphanet" />
              <XRef ID="C0265345" DB="MedGen" />
              <XRef ID="MONDO:0007922" DB="MONDO" />
              <XRef Type="MIM" ID="153400" DB="OMIM" />
            </Trait>
          </TraitSet>
        </ConditionList>
      </GermlineClassification>
    </Classifications>
    <ClinicalAssertionList>
      <ClinicalAssertion ID="7569982" SubmissionDate="2023-09-19" DateLastUpdated="2023-10-21" DateCreated="2023-10-21">
        <ClinVarSubmissionID localKey="NM_005251.2:c.908_923dup|LYMPHEDEMA-DISTICHIASIS SYNDROME" submittedAssembly="GRCh37" />
        <ClinVarAccession Accession="SCV004046257" DateUpdated="2023-10-21" DateCreated="2023-10-21" Type="SCV" Version="1" SubmitterName="Rady Children's Institute for Genomic Medicine, Rady Children's Hospital San Diego" OrgID="506081" OrganizationCategory="laboratory" OrgAbbreviation="RCIGM" />
        <RecordStatus>current</RecordStatus>
        <Classification>
          <ReviewStatus>criteria provided, single submitter</ReviewStatus>
          <GermlineClassification>Pathogenic</GermlineClassification>
          <Comment>This frameshifting variant in exon 1 of 1 introduces a premature stop codon and is predicted to result in loss of normal protein function through protein truncation. This variant has not been previously reported or functionally characterized in the literature to our knowledge; however, nearby loss of function variants have been reported in FOXC2-related disorders and loss-of-function variation in FOXC2 is an established mechanism of disease (PMID: 11499682; 24167460). The c.908_923dup (p.Pro309AlafsTer159) variant is absent from the gnomAD population database and thus is presumed to be rare. Analysis of the parental samples was negative for the variant, indicating this variant likely occurred as a de novo event. Based on the available evidence, the c.908_923dup (p.Pro309AlafsTer159) variant is classified as Pathogenic.</Comment>
        </Classification>
        <Assertion>variation to disease</Assertion>
        <AttributeSet>
          <Attribute Type="AssertionMethod">ACMG Guidelines, 2015</Attribute>
          <Citation>
            <ID Source="PubMed">25741868</ID>
          </Citation>
        </AttributeSet>
        <ObservedInList>
          <ObservedIn>
            <Sample>
              <Origin>germline</Origin>
              <Species TaxonomyId="9606">human</Species>
              <AffectedStatus>yes</AffectedStatus>
            </Sample>
            <Method>
              <MethodType>clinical testing</MethodType>
            </Method>
            <ObservedData>
              <Attribute Type="Description">not provided</Attribute>
            </ObservedData>
          </ObservedIn>
        </ObservedInList>
        <SimpleAllele>
          <GeneList>
            <Gene Symbol="FOXC2" />
          </GeneList>
          <VariantType>Variation</VariantType>
          <AttributeSet>
            <Attribute Type="HGVS">NM_005251.2:c.908_923dup</Attribute>
          </AttributeSet>
        </SimpleAllele>
        <TraitSet Type="Disease">
          <Trait Type="Disease">
            <Name>
              <ElementValue Type="Preferred">LYMPHEDEMA-DISTICHIASIS SYNDROME</ElementValue>
            </Name>
          </Trait>
        </TraitSet>
        <SubmissionNameList>
          <SubmissionName>SUB13808474</SubmissionName>
        </SubmissionNameList>
      </ClinicalAssertion>
    </ClinicalAssertionList>
    <TraitMappingList>
      <TraitMapping ClinicalAssertionID="7569982" TraitType="Disease" MappingType="Name" MappingValue="LYMPHEDEMA-DISTICHIASIS SYNDROME" MappingRef="Preferred">
        <MedGen CUI="C0265345" Name="Distichiasis-lymphedema syndrome" />
      </TraitMapping>
    </TraitMappingList>
  </ClassifiedRecord>
</VariationArchive>

